<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="29106">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02727816</url>
  </required_header>
  <id_info>
    <org_study_id>EX-MKTG-65</org_study_id>
    <nct_id>NCT02727816</nct_id>
  </id_info>
  <brief_title>Non-dispensing Fitting Study Comparing the Clinical Performance Hydrogel Sphere Design Contact Lenses.</brief_title>
  <official_title>Non-dispensing Fitting Study Comparing the Clinical Performance Hydrogel Sphere Design Contact Lenses.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this non-dispensing study is to evaluate the clinical performance of different
      hydrogel contact lens designs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a 35-subject, double masked, randomized, contra lateral, non-dispensing fitting
      trial comparing different hydrogel lens materials.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Centration - pair one</measure>
    <time_frame>Up to 1 hour</time_frame>
    <description>Centration for filcon IV I (BC 8.6) / ocufilcon D (pair one) is assessed. (optimum, decentration acceptable, decentration unacceptable).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Centration - pair two</measure>
    <time_frame>Up to 1 hour</time_frame>
    <description>Centration for filcon IV I (BC 8.7) / ocufilcon D (pair two) is assessed. (optimum, decentration acceptable, decentration unacceptable).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Centration - pair three</measure>
    <time_frame>Up to 1 hour</time_frame>
    <description>Centration for methafilcon A (BC 8.6) / ocufilcon D (pair three) is assessed. (optimum, decentration acceptable, decentration unacceptable).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Centration - pair four</measure>
    <time_frame>Up to 1 hour</time_frame>
    <description>Centration for methafilcon A (BC 8.7) / somofilcon A (pair four) is assessed. (optimum, decentration acceptable, decentration unacceptable).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-blink movement - pair one</measure>
    <time_frame>Up to 1 hour</time_frame>
    <description>Post-blink movement for filcon IV I (BC 8.6) / ocufilcon D (pair one) is assessed. (0-5 Likert scale, 0=Insufficient, unacceptable movement, 4=Excessive, unacceptable movement).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-blink movement - pair two</measure>
    <time_frame>Up to 1 hour</time_frame>
    <description>Post-blink movement for filcon IV I (BC 8.7) / ocufilcon D (pair two) is assessed. (0-5 Likert scale, 0=Insufficient, unacceptable movement, 4=Excessive, unacceptable movement).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-blink movement - pair three</measure>
    <time_frame>Up to 1 hour</time_frame>
    <description>Post-blink movement for methafilcon A (BC 8.6) / ocufilcon D (pair three) is assessed. (0-5 Likert scale, 0=Insufficient, unacceptable movement, 4=Excessive, unacceptable movement).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-blink movement - pair four</measure>
    <time_frame>Up to 1 hour</time_frame>
    <description>Post-blink movement for methafilcon A (BC 8.7) / somofilcon A (pair four) is assessed. (0-5 Likert scale, 0=Insufficient, unacceptable movement, 4=Excessive, unacceptable movement).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens tightness - pair one</measure>
    <time_frame>Up to 1 hour</time_frame>
    <description>Lens tightness on push on test for filcon IV I (BC 8.6) / ocufilcon D (pair one) is assessed. (0% - 100% in 5% steps, 100%=No movement, 50%=Optimum 0%=Falls from cornea without lid support)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens tightness - pair two</measure>
    <time_frame>Up to 1 hour</time_frame>
    <description>Lens tightness on push on test for filcon IV I (BC 8.7) / ocufilcon D (pair two) is assessed. (0% - 100% in 5% steps, 100%=No movement, 50%=Optimum 0%=Falls from cornea without lid support)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens tightness - pair three</measure>
    <time_frame>Up to 1 hour</time_frame>
    <description>Lens tightness on push on test for methafilcon A (BC 8.6) / ocufilcon D (pair three) is assessed. (0% - 100% in 5% steps, 100%=No movement, 50%=Optimum 0%=Falls from cornea without lid support)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens tightness - pair four</measure>
    <time_frame>Up to 1 hour</time_frame>
    <description>Lens tightness on push on test for methafilcon A (BC 8.7) / somofilcon A (pair four) is assessed. (0% - 100% in 5% steps, 100%=No movement, 50%=Optimum 0%=Falls from cornea without lid support)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall fit acceptance - pair one</measure>
    <time_frame>Up to 1 hour</time_frame>
    <description>Overall fit acceptance for filcon IV I (BC 8.6) / ocufilcon D (pair one) is assessed. (Scale 0-4, 0=Should not be worn, 1=Borderline but unacceptable, 2=Minimal acceptable, early review, 3=Not perfect but OK (okay) to dispense, 4=Perfect).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall fit acceptance - pair two</measure>
    <time_frame>Up to 1 hour</time_frame>
    <description>Overall fit acceptance for filcon IV I (BC 8.7) / ocufilcon D (pair two) is assessed. (Scale 0-4, 0=Should not be worn, 1=Borderline but unacceptable, 2=Minimal acceptable, early review, 3=Not perfect but OK to dispense, 4=Perfect).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall fit acceptance - pair three</measure>
    <time_frame>Up to 1 hour</time_frame>
    <description>Overall fit acceptance for methafilcon A (BC 8.6) / ocufilcon D (pair three) is assessed. (Scale 0-4, 0=Should not be worn, 1=Borderline but unacceptable, 2=Minimal acceptable, early review, 3=Not perfect but OK to dispense, 4=Perfect).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall fit acceptance - pair four</measure>
    <time_frame>Up to 1 hour</time_frame>
    <description>Overall fit acceptance for methafilcon A (BC 8.7) / somofilcon A (pair four) is assessed. (Scale 0-4, 0=Should not be worn, 1=Borderline but unacceptable, 2=Minimal acceptable, early review, 3=Not perfect but OK to dispense, 4=Perfect).</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>filcon IV I (BC 8.6) / ocufilcon D (pair one)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants wear a pair of lenses, with a test lens in one eye and a control lens in the contra lateral eye.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>filcon IV I (BC 8.7) / ocufilcon D (pair two)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants wear a pair of lenses, with a test lens in one eye and a control lens in the contra lateral eye.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>methafilcon A (BC 8.6) / ocufilcon D (pair three)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants wear a pair of lenses, with a test lens in one eye and a control lens in the contra lateral eye.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>methafilcon A (BC 8.7) / somofilcon A (pair four)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants wear a pair of lenses, with a test lens in one eye and a control lens in the contra lateral eye.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>filcon IV I (BC 8.6)</intervention_name>
    <description>control lens</description>
    <arm_group_label>filcon IV I (BC 8.6) / ocufilcon D (pair one)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>filcon IV I (BC 8.7)</intervention_name>
    <description>control lens</description>
    <arm_group_label>filcon IV I (BC 8.7) / ocufilcon D (pair two)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ocufilcon D</intervention_name>
    <description>test lens</description>
    <arm_group_label>filcon IV I (BC 8.6) / ocufilcon D (pair one)</arm_group_label>
    <arm_group_label>filcon IV I (BC 8.7) / ocufilcon D (pair two)</arm_group_label>
    <arm_group_label>methafilcon A (BC 8.6) / ocufilcon D (pair three)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>methafilcon A (BC 8.6)</intervention_name>
    <description>control lens</description>
    <arm_group_label>methafilcon A (BC 8.6) / ocufilcon D (pair three)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>methafilcon A (BC 8.7)</intervention_name>
    <description>control lens</description>
    <arm_group_label>methafilcon A (BC 8.7) / somofilcon A (pair four)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>somofilcon A</intervention_name>
    <description>test lens</description>
    <arm_group_label>methafilcon A (BC 8.7) / somofilcon A (pair four)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        A person is eligible for inclusion in the study if he/she:

          -  Is between 18 and 40 years of age (inclusive).

          -  Has had a self-reported visual exam in the last two years.

          -  Is an adapted soft CL (Contact Lens) wearer.

          -  Has a CL spherical prescription between - 1.00 and - 6.00 (inclusive)

          -  Has a spectacle cylinder up to 0.75D (Diopters) in each eye.

          -  Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or
             better in each eye.

          -  Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye
             with the study contact lenses.

          -  Has clear corneas and no active ocular disease.

          -  Has read, understood and signed the information consent letter.

          -  Patient contact lens refraction should fit within the available parameters of the
             study lenses.

          -  Is willing to comply with the wear schedule.

          -  Is willing to comply with the visit schedule.

        Exclusion Criteria:

        A person will be excluded from the study if he/she:

          -  Has never worn contact lenses before.

          -  Currently wears rigid gas permeable contact lenses.

          -  Has a history of not achieving comfortable CL wear (5 days per week; &gt; 8 hours/day)

          -  Has a CL prescription outside the range of - 1.00 to - 6.00D

          -  Has a spectacle cylinder â‰¥1.00D of cylinder in either eye.

          -  Has contact lens best corrected distance vision worse than 20/25 (0.10 logMAR) in
             either eye.

          -  Presence of clinically significant (grade 2-4) anterior segment abnormalities.

          -  Presence of ocular or systemic disease or need of medications which might interfere
             with contact lens wear.

          -  Slit lamp findings that would contraindicate contact lens wear such as:

               -  Pathological dry eye or associated findings

               -  Pterygium, pinguecula, or corneal scars within the visual axis

               -  Neovascularization &gt; 0.75 mm in from of the limbus

               -  Giant papillary conjunctivitis (GPC) worse than grade 1

               -  Anterior uveitis or iritis (past or present)

               -  Seborrheic eczema, Seborrheic conjunctivitis

               -  History of corneal ulcers or fungal infections

               -  Poor personal hygiene

          -  Has a known history of corneal hypoesthesia (reduced corneal sensitivity)

          -  Has aphakia, keratoconus or a highly irregular cornea.

          -  Has Presbyopia or has dependence on spectacles for near work over the contact lenses.

          -  Has undergone corneal refractive surgery.

          -  Is participating in any other type of eye related clinical or research study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Optometry Clinic, National Autonomous University</name>
      <address>
        <city>Mexico D.F.</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 6, 2016</lastchanged_date>
  <firstreceived_date>March 30, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
